Detalhe da pesquisa
1.
Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
Pharm Res
; 34(8): 1741-1750, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536971
2.
Comparative Study of Different Nano-Formulations of Curcumin for Reversal of Doxorubicin Resistance in K562R Cells.
Pharm Res
; 34(2): 279-289, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815791
3.
Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance.
AAPS PharmSciTech
; 18(4): 1116-1124, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27600324
4.
Polymeric modification and its implication in drug delivery: poly-ε-caprolactone (PCL) as a model polymer.
Mol Pharm
; 9(9): 2365-79, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22823097
5.
1,6-heptadiynes based cyclopolymerization functionalized with mannose by post polymer modification for protein interaction.
Carbohydr Res
; 508: 108397, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280802
6.
Selection and optimization of nano-formulation of P-glycoprotein inhibitor for reversal of doxorubicin resistance in COLO205 cells.
J Pharm Pharmacol
; 69(7): 834-843, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397291
7.
Nanoformulations for delivery of biomolecules: focus on liposomal variants for siRNA delivery.
Crit Rev Ther Drug Carrier Syst
; 30(6): 469-93, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099397
8.
Poly-Ñ-caprolactone based formulations for drug delivery and tissue engineering: A review.
J Control Release
; 158(1): 15-33, 2012 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21963774